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Abstract Present guidelines discourage the use of
CT coronary angiography (CTCA) in symptomatic
angina patients. We examined the relation between
coronary calcium score (CS) and the performance of
CTCA in patients with stable and unstable angina in
order to understand under which conditions CTCA
might be a gate-keeper to conventional coronary
angiography (CCA) in such patients. We included
360 patients between 50 and 70 years old with stable
and unstable angina who were clinically referred for
CCA irrespective of CS. Patients received CS and
CCTA on 64-slice scanners in a multicenter cross-
sectionaltrial.Theinstitutionalreviewboardapproved
the study. Diagnostic performance of CTCA to detect
or rule out signiﬁcant coronary artery disease was
calculated on a per patient level in pre-deﬁned CS
categories. The prevalence of signiﬁcant coronary
artery disease strongly increased with CS. Negative
CTCAwereassociatedwithanegativelikelihoodratio
of \0.1 independent of CS. Positive CTCA was
associated with a high positive likelihood ratio of 9.4
if CS was\10. However, for higher CS the positive
likelihood ratio never exceeded 3.0 and for CS[400 it
decreasedto1.3.Inthe62(17%)patientswithCS\10,
CTCAreliablyidentiﬁedthe42(68%)ofthesepatients
without signiﬁcant CAD, at no false negative CTCA
scans. In symptomatic angina patients, a negative
CTCA reliably excludes signiﬁcant CAD but the
additional value of CTCA decreases sharply with CS
[10 and especially with CS[400. In patients with CS
\10,CTCAprovidesexcellentdiagnosticperformance.
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Background
Although CT coronary angiography (CTCA) can
reliably rule out coronary artery stenosis in symp-
tomatic angina patients, the speciﬁcity is limited in
these patients [1–3]. Therefore, present guidelines
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patients, as the percentage of conventional coronary
angiograms (CCA) that would be replaced by CTCA
is considered too limited to justify the health risk and
costs associated with CTCA [4, 5]. We speculate that
the inﬂuence of coronary calciﬁcation on the diag-
nostic performance of CTCA may in part explain the
limited speciﬁcity of CTCA in symptomatic angina
patients. First, the prevalence of coronary artery
disease (CAD) increases with coronary CS [6].
Second, blooming artifacts caused by coronary cal-
ciﬁcation resulting in over-estimation of lesion
severity may result in false positive ﬁndings [7, 8].
Previous studies on the inﬂuence of CS on the
diagnostic performance of CTCA have provided
contradictory evidence. As mentioned, some previous
studies have reported a high number of false positive
ﬁndings in patients with a high CS [7, 8]. Also, a
recent large study reported that the speciﬁcity of
CTCA was 86% in subjects with a CS B400, while it
was reduced to 53% in subjects with a CS[400 [1].
However, others have reported no signiﬁcant or only
a limited impact of coronary calciﬁcation on the
diagnostic accuracy of CTCA [9, 10].
In order to understand under which conditions
CTCA might be a gate-keeper to CCA in patients
with stable angina and unstable angina, we examined
the relation between CS and the performance of
CCTA in these patients.
Materials and methods
This cross sectional study was designed to prospec-
tively include symptomatic angina patients who
presented with stable and unstable anginal syndromes
who were referred for clinically indicated CCA
irrespective of CS [3]. Patients were requested to
undergo an additional CTCA for research purposes
besides their CCA. The study protocol was approved
by the institutional review board of the Erasmus
University Medical Center.
As described previously, for this multi-center
multi-vendor study conducted from October 2004
until June 2006 360 patients between 50 and 70 years
of age with stable angina pectoris or non-ST segment
elevation acute coronary syndrome underwent a non-
enhanced CT scan to determine the CS followed by a
CTCA scan in addition to CCA [3]. No patients,
vessels or segments were excluded from the analysis,
even if image quality was poor due to extensive
calciﬁcation, coronary motion or breathing artifacts.
No patients with previous history of percutaneous
transluminal coronary angioplasty, coronary artery
bypass surgery, impaired renal function (serum creat-
inine[120 lmol/l),persistentarrhythmias,inabilityto
perform a breath hold of 15 s or known allergy to
iodinated contrast material, were included. The study
was conducted in three university hospitals.
Patients with a heart rate exceeding 65 beats per
minute (bpm) received additional beta-blockers (up
to 100 mg metoprolol p.o. or up to 20 mg metoprolol
i.v.). All patients received thorough breath hold
instructions.
All scans were performed with 64-slice CT
scanners in Center A (Sensation 64, Siemens, Forch-
heim, Germany), Center B (Brilliance 64, Philips
Medical Systems, Best, The Netherlands) and Center
C (Toshiba Multi-Slice Aquilion 64 system, Toshiba
Medical Systems, Tokyo, Japan). A non-enhanced
scan to calculate the total CS was performed prior to
CTCA. The scan parameters of the scanners are listed
in Table 1. A bolus-tracking technique was used to
synchronize the start of image acquisition with the
arrival of contrast agent in the coronary arteries. The
effective dose of the nonenhanced scan and the
CTCA was estimated from the product of the dose-
length product and a conversion coefﬁcient
(k = 0.017 mSv/[mGy 9 cm]) for the chest as the
investigated anatomical region [11].
Multiple datasets were reconstructed separately
with retrospective ECG-gating in order to obtain
optimal image quality for all coronary segments. The
Agatston CS was calculated using dedicated software
(Heartbeat-CS, Extended Brilliance Workspace, Phi-
lips Medical System, Best, The Netherlands) [12].
CTCA scans were evaluated by two experienced
readers, blinded for the CCA results, for lumen
stenosis[50% based on a visual estimate, using the
axial images and multiplanar reformatted images. In
case of disagreement, a third reader was consulted.
The kappa-value for inter- and intraobserver vari-
ability was 0.70 and 0.72, respectively.
All CCAs, which were used as the standard of
reference, were evaluated by a core lab of experi-
enced cardiologists, who were unaware of the results
of the CTCA. Stenoses were evaluated in the CCA
projection with the worst degree of stenosis, and
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123classiﬁed as signiﬁcant if the lumen diameter reduc-
tion exceeded 50% as measured by QCA.
Descriptive statistics were used to evaluate the
diagnostic performance of CS and CTCA to detect
patients with signiﬁcant CAD, including sensitivity,
speciﬁcity, positive and negative predictive values,
and positive and negative likelihood ratios. The
likelihood ratio incorporates both the sensitivity and
speciﬁcity of a test and provides a direct estimate of
how much a test result will change the odds of having
a disease. These diagnostic parameters were
expressed with a 95% conﬁdence interval (CI)
calculated with binomial expansion. The diagnostic
performance of CTCA was calculated for all patients
combined, and for pre-deﬁned subgroups of patients
with an Agatston CS \10, between 10 and 100,
between 100 and 400 and[400 [13].
A Chi-square test was performed to test for
statistical signiﬁcance (p\0.05). All analyses were
repeated separately for patients with stable and
unstable anginal syndromes.
Prevalence of signiﬁcant CAD was based on the
presence of at least one signiﬁcant stenosis as
determined by QCA, which was considered the
standard of reference.
Results
Patient characteristics are listed in Table 2. Two-
hundredandforty-ﬁve (68%) of360studyparticipants
were male, and 233 (65%) presented with stable chest
pain syndromes. The mean age was 60 ± 6 years, the
mean body mass index was 27.3 ± 3.8 kg/m
2 and the
median Agatston CS was 213 (inter-quartile range
42–553). The prevalence of having at least one
signiﬁcant coronary stenosis was 68%. No signiﬁcant
differences in patient demographics were seen in
patients presenting with stable and unstable anginal
syndromes, except for a higher incidence of smokers
and a higher prevalence and extent of signiﬁcant CAD
in the unstable angina patients.
As shown in Table 3, for all patients combined the
sensitivity of CTCA to detect signiﬁcant CAD was
99% (95%CI 97–100%), the speciﬁcity was 64%
(95%CI 55–73%), positive and negative predictive
Table 1 Scan parameters Sensation 64,
Siemens
Brilliance 64,
Philips
Aquilion 64,
Toshiba
CT coronary angiography
Gantry rotation time (ms) 330 420 400
Slices per rotation 32 9 26 4 9 16 4 9 1
Individual detector width
(mm)
0.6 0.625 0.5
Table feed (mm/rotation) 3.8 8 5.76
Tube voltage (kV) 120 120 120
Tube current (mA s) 850–960 900 670–710
Retrospective gating Yes Yes Yes
ECG X-ray tube modulation Off Off Off
Contrast material Iomeron 400 Ultravist 300–370 Iomeron 400
Volume (ml) 95 100–140 80–110
Iodine ﬂux (g/s) 2.0 1.6–2.0 2.0
Estimated effective dose
(mSv)
15.5 ± 2.2 18.4 ± 3.2 16.0 ± 2.3
Calcium score
Tube current (mA s) 150 150 150
ECG-synchronization Retrospective
gating
Retrospective
gating
Prospective
triggering
ECG X-ray tube modulation ON ON –
Estimated radiation exposure 1.7 ± 0.8 1.8 ± 0.9 1.2 ± 0.5
Int J Cardiovasc Imaging (2009) 25:847–854 849
123value were 86% (95%CI 81–89%) and 97% (95%CI
90–100%), respectively. Positive and negative like-
lihood ratios to detect or exclude signiﬁcant CAD
were 2.8 (95%CI 2.2–3.5) and 0.01 (95%CI 0.00–
0.05) for CTCA. Six of 37 (16%) subjects with a CS
of 0, and 15 of 62 (24%) subjects with a CS\10 had
signiﬁcant CAD on CCA. Detection of signiﬁcant
CAD by CTCA was successful in all these subjects.
The estimated average effective radiation exposure
was 1.2 ± 0.5 to 1.8 ± 0.9 mSv for CS and
15.5 ± 2.2 to 18.4 ± 3.2 mSv for CTCA.
With increasing CS the prevalence of signiﬁcant
CAD increased steeply (Table 3). Whereas for
patients with a CS\10 the prevalence of signiﬁcant
CAD was 24%, in those with a CS[400 it was 87%.
Negative CTCA scans were associated with a nega-
tive likelihood ratio of 0.0–0.1 independent of CS
(Table 3). A positive CTCA was associated with a
high positive likelihood ratio of 9.4 (95%CI 4.1–22)
if CS was\10. However, for higher CS the positive
likelihood ratio never exceeded 3.0 and for CS[400
it decreased to 1.3 (95%CI 1.0–1.6). Also, the
speciﬁcity of CTCA diminished signiﬁcantly with
increasing CS (Table 3). In patients with a CS \10
speciﬁcity was 89% (95%CI 76–96%). For higher CS
speciﬁcity never exceeded 59% and for CS [400
Table 2 Patient characteristics
Variable All patients
(N: 360, 100%)
Stable anginal syndromes
(N: 233, 65%)
Unstable anginal syndrome
(N: 127, 35%)
p
Typical angina pectoris 151 (42%) 151 (65%) – –
Atypical angina pectoris 82 (23%) 82 (35%) –
Unstable angina pectoris 127 (35%) – 127 (100%)
Men 245 (68%) 156 (67%) 89 (70%) 0.56
Age (years)
a 60 ± 66 0 ± 66 0 ± 6 0.72
Body mass index (kg/m
2)
a 27.3 ± 3.8 27.6 ± 3.9 26.8 ± 3.5 0.06
Heart rate (bpm)
a 59 ± 95 9 ± 10 59 ± 8 0.99
Risk factors
Hypertension
b 219 (61%) 149 (64%) 70 (55%) 0.11
Hypercholesterolemia
c 228 (63%) 151 (65%) 77 (61%) 0.49
Diabetes mellitus
d 63 (18%) 47 (20%) 16 (13%) 0.08
Smoker 137 (38%) 74 (32%) 63 (50%) 0.001
Family history of CAD 183 (51%) 113 (48%) 70 (55%) 0.27
Body mass index C 30 kg/m
2 85 (24%) 59 (25%) 26 (20%) 0.36
Previous myocardial infarction 53 (15%) 36 (15%) 17 (13%) 0.64
Calcium score (Agatston score)
e 213 (42–553) 211 (31–639) 216 (44–478) 0.59
Conventional coronary angiography
Prevalence of obstructive CAD 246 (68%) 146 (63%) 100 (79%) 0.002
Absence of signiﬁcant CAD 114 (32%) 87 (37%) 27 (21%) 0.009
Single vessel disease 141 (39%) 88 (38%) 53 (42%)
Two vessel disease 78 (22%) 46 (20%) 32 (25%)
Three vessel disease 21 (6%) 10 (4%) 11 (9%)
Left main coronary artery disease 6 (2%) 2 (1%) 4 (3%)
a Mean and standard deviation
b Blood pressure C140/90 mm Hg or treatment for hypertension
c Total cholesterol[180 mg/dl or treatment for hypercholesterolemia
d Treatment with oral anti-diabetic medication or insulin
e Median and quartiles. Values are n (%) unless otherwise indicated. Categorical variables were tested with Fisher exact and chi
square test. Continuous variables were tested with unpaired two sided student t test. If not normally distributed, continuous variables
were compared with the Mann–Whitney test. p-Values are signiﬁcant if values\0.05
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123decreased to 20% (95%CI 5–49%). Only 3 of 15
patients with a CS[400 and no signiﬁcant CAD on
CCA were evaluated as negative by CTCA. As shown
in Table 4, the impact of CS on the diagnostic
performance of CTCA is similar for patients with
stable and unstable anginal syndromes. A CS \10
was present in 43 of 233 (18%) stable angina patients
and in 19 of 127 (15%) unstable angina patients. In
43 stable angina patients and 19 unstable angina
patients with CS\10, CTCA correctly identiﬁed 32
(74%) stable angina patients and 10 (53%) unstable
angina patients in whom no signiﬁcant CAD was
present on CCA, at no false negative CTCA scans.
Discussion
In this study we set out to determine the relation
between CS and the performance of CCTA in
symptomatic stable and unstable angina patients in
order to understand under which conditions CTCA
might be a gate-keeper to CCA in such patients. We
report that, in symptomatic angina patients, a negative
CTCA reliably excludes signiﬁcant CAD independent
of CS but that the speciﬁcity and the positive
likelihood ratio of CTCA decrease sharply with CS
[10, and especially with CS [400. Thus, in symp-
tomatic angina patients with a CS[10, and especially
in those with a CS[400, CTCA has limited additional
value in the diagnostic work-up. In the 17% of
symptomatic angina patients with a CS\10, CTCA
provides excellent negative and positive likelihood
ratios for the detection or ruling out of signiﬁcant
CAD. CTCA correctly identiﬁes the 74% of stable
angina patients and 53% of unstable angina patients
with a CS\10 without signiﬁcant CAD in whom no
CCA would be necessary, at no false negative scans.
The negative inﬂuence of CS on the diagnostic
performance of CTCA was especially apparent in
patients with a CS[400, in whom the speciﬁcity was
only 20% (95%CI 5–49%) and the positive likelihood
ratio was only 1.3 (95%CI 1.0–1.6). Ninety-nine of
114 (87%) patients with a CS [400 had signiﬁcant
CAD on CCA. Of the remaining 15 patients, i.e. those
with a CS [400 and no signiﬁcant CAD on CCA,
only 3 were evaluated as negative by CTCA. Two
factors may account for the latter ﬁndings. The 87%
prevalence of signiﬁcant CAD in patients with a CS
[400 is probably the most important factor. In
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123addition, calcium related blooming artifacts due to
the limited spatial resolution of CTCA may have
caused overestimation of lesion size, and thus false
positive results [7, 8]. These ﬁndings are well in line
with a previous study in which CTCA was of limited
additional value in the diagnostic work-up of symp-
tomatic patients with a high prevalence of signiﬁcant
CAD [14].
As mentioned above, previous studies on the
impact of CS on the diagnostic impact of CTCA
are contradictory. A previous large study reported
that the speciﬁcity of CTCA was 86% in subjects
with a CS B400, while it was 53% in subjects with a
CS[400 [1]. Unfortunately, no data on the diagnostic
performance of CTCA in subcategories of CS\400
were reported. Also, two other previous studies found
that coronary calciﬁcation was one of the main
factors leading to false positive results [7, 8].
However, Pundziute et al. reported no signiﬁcant
impact of a CS[400 on the diagnostic performance
of CTCA in 110 patients clinically referred for CCA
[10]. Also, Cademartiri et al. [9] divided 120 patients
clinically referred for CCA in groups with a CS
below and above the median Agatston CS of 55. He
reported that the diagnostic performance of CTCA
was affected only to a small extent by the CS. The
prevalence of signiﬁcant CAD and the CS of our
population are similar to the previous studies men-
tioned, yet our study is a multicenter multivendor
study and it has included substantially more subjects.
Interestingly, in a recent study in 664 asymptom-
atic individuals the prevalence of at least one
signiﬁcant stenosis on CTCA increased from 7.9%
for patients with a CS between 1 and 100 to 14.5%
for patients with a CS between 400 and 1,000 [15].
Unfortunately, no CCA data were available for this
study. Thus, due to the absence of a standard of
reference the diagnostic performance of CTCA for
the detection of signiﬁcant CAD could not be
determined. The prevalence of signiﬁcant CAD in
the highest CS categories was signiﬁcantly lower than
in our study. This could be explained by the fact that
the former study included asymptomatic subjects
whereas we studied symptomatic angina patients.
Importantly however, CCA merely provides infor-
mation on vessel lumen while CTCA also gives
information on stenosis location and size, plaque
burden, and plaque composition [16]. Future research
is needed to determine the clinical value of this
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123information, and speciﬁcally so in stable and unstable
patients with a high CS in whom CTCA seems to
have limited additional value if only the detection of
signiﬁcant CAD is taken into consideration.
When compared to most previous studies, the
present study has included a larger number of
subjects in a multicenter multivendor setting, allow-
ing for a more reliable subgroup analysis. However,
we acknowledge limitations of our study. Most
importantly, in line with most previous studies, our
subjects were derived from a selected population of
symptomatic stable and unstable angina patients who
were referred for CCA for clinical reasons. Thus our
ﬁndings only apply to symptomatic stable and
unstable angina patients. Future studies will need to
address the value of CTCA in the diagnostic work-up
of asymptomatic patients with a high CS. Secondly,
in the present study 64-slice CTCA scanners were
used. Future research will need to determine whether
improvements in spatial and temporal resolution with
new generation scanners using dual source tech-
niques, dual energy techniques or more detector rows
may improve the diagnostic performance of CTCA in
patients with a high CS. Thirdly, we only studied
patients between 50 and 70 years of age. The median
CS for patients under 50 years of age is likely to be
lower, and that of patients over 70 years of age is
likely to be higher than the median CS of our
population [17, 18]. As the association between CS
and signiﬁcant CAD varies with age [17, 18], our
ﬁndings may not fully apply to subjects outside this
age range. Fourthly, in line with previous studies, we
excluded patients who were not in stable sinus
rhythm, or did have renal insufﬁciency. In addition,
a limited number of patients was not included for
logistic reasons. Finally, the present study only
focused on anatomical data. Additional research
should focus on the value of the combination of
CS, CTCA and functional tests such as Positron
Emission Tomography and Single Photon Emission
Computed Tomography in the diagnostic work-up of
angina patients referred for CCA.
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